close

Dai-ichi Karkaria Ltd

Know More
NSEBSE
Stock not tradded

461.30-13.50 (-2.84%)

04:01 PM,25th Sep 2023

BSE : 526821

NSE : DAICHIKARK

Sector : Industrials

ISIN Code : INE928C01010

  • NSE
  • BSE
  • 1D
  • 5D
  • 1M
  • 6M
  • 1Y
  • 2Y
  • 5Y
  • MAX

Last Updated: Sep 25 2023 | 04:01 PM IST

Market Cap (₹ Cr)

0

Turnover (₹ Cr)

0.00

Volume (Shares)

Face Value

10

52-WK High

0.00

52-WK High Date

Invalid date

52-WK Low

0.00

52-WK Low Date

Invalid date

All Time High

88.00

All Time High Date

19 Dec 1995

All Time Low

10.00

All Time Low Date

05 Sep 2000

Dai-ichi Karkaria Ltd

Dai Ichi Karkaria (DIK) manufactures speciality chemicals has a tie-up with Matsumoto to manufacture spin finishes which are used for imparting lubrication and anti-static properties to textile filaments and yarns. It is now expanding its production capacity from 750 tpa to 3000 tpa.DIK had set up a unit to manufacture certain bulk drugs omeprazole menadione and calcium pentothenate the last two will be manufactured in India for the first time. DIK is also setting up a unit to manufacture 600 tpa of polyacrylamide-based flocculents which are used for solid-liquid separation.The expansion cum Diversification plan for High Molecular Weight Flocculants Project at Kurkumbh has been successfully completed. Company had joint venture with project consultant for effluent treatment plants for increasing business. Company Bulk Drugs & Fine Chemical Projects for patented molecule processes were developed and were scaled up to commercial level by March-99. Company plans to start development of three new products in the pilot facility which is being upgraded presently to meet strict cGMP condition. Company also negotiating with foreign customer for product specific tie-ups in future. Company Spin fishes continue to do well & POY DTY finish has been accepted in the market & company hopes to get orders from leading synthetic fibre manufacturers.During the year 1999-2000 the company's successfully introduced eight new products in therapeutic areas of cardiovascular antihistaminics analgesics anxiolytic antidepressant and anticonsulgants.The diversification programme which was taken up by the company is focusing in the three major areas are ETPpaper and Alumina industry.

Dai-ichi Karkaria Ltd - Key Fundamentals

PARAMETER VALUES
Market Cap (₹ Cr)

343

EPS - TTM (₹) [S]

13.48

P/E Ratio (X) [S]

2.32

Face Value (₹) 10
Latest Dividend (%)40.00
Latest Dividend Date 15 Sep 2023
Dividend Yield (%) 0.87
Book Value Share (₹) [S]198.56
P/B Ratio (₹) [S]2.32
[*C] Consolidated [*S] Standalone

Funds Owing this Stock

Scheme Name Amount Invested ( ₹ Cr ) No Of Shares Net Asset (%)

Research Reports

Date BrokerActionPrices(Rs)Report
Data Not Found

Stock Strength

Today's Low/High

461.30

479.00

Week Low/High

461.30

520.00

Month Low/High

400.00

520.00

Year Low/High

285.00

520.00

All time Low/High

5.50

625.00

Share Price Returns

Period BSENSE SENSEXNIFTY
1 Week-8.45%%-2.33-2.28%
1 Month9.34%%1.752.12%
3 Month20.26%%4.835.41%
6 Month28.75%%14.7716.11%
1 Year43.77%%13.6413.55%
3 Year57.76%%76.5978.05%

Financials

Graph
Table

Bulk/ Block

ALL
NSE
BSE
ALL
BUY
SELL
DateClient NameExchangeTransactionQuantityPrice
08-03-2021KRISHNAMURTHY NARAYANAN IYERBSEBUY40000330.49
11-03-2016CHEMICALS AND FERRO ALLOYS PRIVATE LIMITEDBSESELL257000335.00
11-03-2016SHERNAZ FIROZE VAKILBSEBUY423333335.00
11-03-2016SHERNAZ FIROZE VAKILBSEBUY166333335.00
11-03-2016SHERNAZ FIROZE VAKILBSEBUY257000335.00
11-03-2016UNIVERSAL FERRO & ALLIED CHEMICALS LIMITEDBSESELL166333335.00
20-06-2013ASHOKKUMAR PARMARBSESELL19460548.00
20-06-2013SHERNAZ FIROZE VAKILBSEBUY20700048.00
07-07-2009DAI ICHI KARKARIA LIMITEDBSEBUY12256135.89
07-07-2009KAUSHIK SHEKHARBSESELL9000035.90

Load More

Peer Group Comparison

NamePrice(In Rs)Chg(%)Mkt Cap(Rs Cr)Sales(Rs Cr)Profit(Rs Cr)EPS(Rs)P/E(x)

Shareholding Pattern

Jun 2023
Archive
CategoryShare(%)
Promoter63.88
Financial Institutions Banks0.00
Foreign Institutional Investors0.00
Insurance Companies0.00
Mutual Funds Uti0.00
Other Institutional Investors0.35
Indian Public28.27
Others Non Institutional Investors7.50
Custodians0.00

Corporate Action

Announcement DatePurposeFromToRemarks
Data Not Found

Price History

Search for Price History

DateOpenHighLowCloseSharesTrades
Data Not Found

Load more

Company Info

Company Information

Chairperson & Managing Direct : S F Vakil

Director : A H Jehangir

Independent Director : K D Patel

Independent Director : K M Elavia

Whole Time Director & COO : Meher Vakil

Independent Director : Ashok V Hiremath

Company Sec. & Compli. Officer : Ankit Shah

Registered Office: Liberty Cinema Building, Sir Vithaldas Thackersey Marg,Mumbai,Maharashtra-400020 Ph: 91-022-22017130/22015895

Email:investor@dai-ichiindia.com

URL:http://www.dai-ichiindia.com